Unichem Labs: No observation from USFDA

| Updated on: Apr 20, 2018

Drug firm Unichem Laboratories on Friday said it has not received any observations from the US health regulator following completion of inspection of the company’s facility in Ghaziabad, Uttar Pradesh. The facility was inspected by the United States Food and Drug Administration from April 16 to April 20, Unichem Laboratories said, and added that this inspection also covered one of the ‘first to file’ molecules. Shares of the company may see buying interest on this announcement.

Published on April 20, 2018
This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you